finance.yahoo.com ·
prestige consumer healthcare q4 earnings 070754061
Topic context
This topic has been covered 379499 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedPrestige Consumer Healthcare's Q4 revenue decline is driven by supply constraints in the Clear Eyes product line and shipping disruptions from the Middle East conflict. The company's consumer healthcare products face input cost and logistics pressures, with margin compression evident in lower EPS. Impact is company-specific but reflects broader OTC healthcare supply chain vulnerabilities.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Prestige Consumer Healthcare Q4 revenue $281.6M, down 5% YoY
- Supply constraints in Clear Eyes product line
- Shipping disruptions linked to Middle East conflict
- Full-year adjusted EPS $4.38 vs $4.52 prior year
- Fiscal 2027 organic revenue growth guidance 1-3%, adjusted EPS $4.42-$4.51
Sustained freight rate increases of 5-10% expected over 2-4 weeks due to ongoing Middle East disruptions.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- CONSUMER_STAPLESmid
- LOGISTICS_SHIPPINGmid
- LOGISTICS_SHIPPINGshort
